ConductScience.org, home

Paper42882002PubMed

MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management.

Krzewiński H and 2 others. J Clin Med, 2026.

Cite this record

ConductScience Library. MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management. Papers, record 42882002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42882002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management.
Journal
J Clin Med
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-20

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krzewiński HHuberthttps://orcid.org/0009-0003-3079-6046
2Wątroba OOliwier
3Koza JJarosław

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139152050Cardiovascular disease assessment and management in liver transplantation.Eur Heart J2024https://conductscience.org/library/papers/39152050PubMed
241899181Alcohol Abstinence Is Associated with Regression of Non-Invasive Fibrosis Markers in Patients with Metabolic Syndrome: A 12-Month Prospective Study.J Clin Med2026https://conductscience.org/library/papers/41899181PubMed
338851997EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).J Hepatol2024https://conductscience.org/library/papers/38851997PubMed
437364790A multisociety Delphi consensus statement on new fatty liver disease nomenclature.J Hepatol2023https://conductscience.org/library/papers/37364790PubMed
535120736Baveno VII - Renewing consensus in portal hypertension.J Hepatol2022https://conductscience.org/library/papers/35120736PubMed
617916548Assessment of hepatic fibrosis with magnetic resonance elastography.Clin Gastroenterol Hepatol2007https://conductscience.org/library/papers/17916548PubMed
726542285Adipocyte lipolysis and insulin resistance.Biochimie2016https://conductscience.org/library/papers/26542285PubMed
839996356Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.Diabetes Obes Metab2025https://conductscience.org/library/papers/39996356PubMed
937868808Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential.Toxicol Rep2023https://conductscience.org/library/papers/37868808PubMed
1039362716Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease.Clin Liver Dis2024https://conductscience.org/library/papers/39362716PubMed
1122563376Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model.PLoS One2012https://conductscience.org/library/papers/22563376PubMed
1241812830Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.Gastroenterology2026https://conductscience.org/library/papers/41812830PubMed
1341728070MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyond.Gastroenterol Rep (Oxf)2026https://conductscience.org/library/papers/41728070PubMed
1441459093Metabolic dysfunction and alcohol-associated liver disease (MetALD).eGastroenterology2025https://conductscience.org/library/papers/41459093PubMed
1520180235Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.World J Gastroenterol2010https://conductscience.org/library/papers/20180235PubMed
1640832962Serum fibrosis scores as predictors of liver fibrosis and long-term outcomes in metabolic dysfunction-associated steatotic liver disease, including cirrhosis.Rev Invest Clin2025https://conductscience.org/library/papers/40832962PubMed
1738174913ACG Clinical Guideline: Alcohol-Associated Liver Disease.Am J Gastroenterol2024https://conductscience.org/library/papers/38174913PubMed
1828407655EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version).Ultraschall Med2017https://conductscience.org/library/papers/28407655PubMed
1933588101Transient Elastography Accurately Screens for Compensated Advanced Chronic Liver Disease in Patients With Ongoing or Recent Alcohol Withdrawal.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/33588101PubMed
2038858523Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.Nat Med2024https://conductscience.org/library/papers/38858523PubMed

See all 93 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42882002

GET https://conductscience.org/api/papers/v1/42882002/references?page=2